Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06WUK
|
||||
Former ID |
DIB014526
|
||||
Drug Name |
Carlumab
|
||||
Synonyms |
CCL-2; CNTO-888; Anti-MCP1 monoclonal antibodies, Centocor; CCL2 monoclonal antibody (infusion, cancer), Centocor
|
||||
Drug Type |
Antibody
|
||||
Company |
Janssen biotech
|
||||
CAS Number |
CAS 915404-94-3
|
||||
Target and Pathway | |||||
Target(s) | C-C motif chemokine 2 | Target Info | [532844] | ||
References | |||||
Ref 532844 | Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol. 2015 Mar;10(1):111-23. | ||||
Ref 542685 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 771). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.